These therapies work by helping the immune system recognize and respond to cancer cells more effectively.
Engineered antibodies can target specific molecules or characteristics associated with cancer cells.
This approach uses dendritic cells, which play an important role in presenting cancer-related information to the immune system.
Natural killer cells are immune cells with the ability to recognize and destroy certain abnormal cells.
+
+